Release Date: 30/10/09 10:05 Summary: Appendix 4C - quarterly Price Sensitive: Yes Download Document 92.6KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%